When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Great minds with great ideas usually share in the midst of their persecution" - Jeremy Aldana
Today, we look at a small antibiotic concern. This 'busted IPO' comes from across the pond and recently received FDA approval for its primary drug candidate. We provide an in-depth 'deep dive' in the paragraphs below.
Company Overview
Nabriva Therapeutics plc (NBRV) is a Dublin, Ireland-based biopharmaceutical concern focused on the development of antibiotics to treat serious infections. The company has two primary assets. One (Xenleta) received FDA approval on August 19, 2019; for the other